Ulcerative colitis (UC) is a refractory disease characterized by symptoms such asdiarrhea, bloody stools, and abdominal pain with repeated relapses and remissions.
Evaluation of UC activity is important, and endoscopic evaluations of mucosal
inflammation can facilitate subsequent prognostication. On the basis of these
considerations, achievement of mucosal healing is important in inflammatory bowel disease
(IBD), and evaluation of IBD using endoscopy is extremely important. However, endoscopic
examinations are associated with problems such as physical burden to the patient, cost,
and risk of complications.
Thus, to avoid the need for frequent endoscopy, noninvasive biomarkers that accurately
reflect the endoscopic activity of UC have emerged, and fecal calprotectin (FC) and the
fecal immunochemical occult blood test (FIT) are being widely used in clinical practice.
Diagnostic Test: Oncostatin M
Test to diagnosis of Ulcerative colitis
Inclusion Criteria:
- All patients aged >18 years and <80 years, of both gender who diagnosed to have UC
and given the consent for participation in the study
Exclusion Criteria:
- 1- Any patient with systemic inflammation as Bronchial asthma. 2- History of cancer
or tumor. 3- Autoimmune disease such as rheumatoid arthritis and systemic lupus
erythematous
Not Provided
Not Provided